{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:02:05Z","timestamp":1789538525816,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01453-6","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T16:11:40Z","timestamp":1789488700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SAT1 promotes prostate cancer progression and decreases enzalutamide sensitivity by enhancing spermine catabolism"],"prefix":"10.1007","volume":"39","author":[{"given":"Yixin","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biqi","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"3","key":"1453_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1453_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamaoncol.2024.0591","volume":"10","author":"M Hussain","year":"2024","unstructured":"Hussain M, Fizazi K, Shore ND, et al. Metastatic hormone-sensitive prostate cancer and combination treatment outcomes: a review. JAMA Oncol. 2024;10(6):807\u201320. https:\/\/doi.org\/10.1001\/jamaoncol.2024.0591.","journal-title":"JAMA Oncol"},{"issue":"16","key":"1453_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1056\/NEJMoa2303974","volume":"389","author":"SJ Freedland","year":"2023","unstructured":"Freedland SJ, de Almeida Luz M, De Giorgi U, et al. Improved outcomes with enzalutamide in biochemically recurrent prostate cancer. N Engl J Med. 2023;389(16):1453\u201365. https:\/\/doi.org\/10.1056\/NEJMoa2303974.","journal-title":"N Engl J Med"},{"issue":"7","key":"1453_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112798","volume":"42","author":"X Li","year":"2023","unstructured":"Li X, Li F, Ye F, et al. Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancer. Cell Rep. 2023;42(7):112798. https:\/\/doi.org\/10.1016\/j.celrep.2023.112798.","journal-title":"Cell Rep"},{"issue":"14","key":"1453_CR5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315509121","volume":"121","author":"D Murthy","year":"2024","unstructured":"Murthy D, Attri KS, Suresh V, et al. The MUC1-HIF-1\u03b1 signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proc Natl Acad Sci U S A. 2024;121(14):e2315509121. https:\/\/doi.org\/10.1073\/pnas.2315509121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1453_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","volume":"43","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhou Z, Du X, et al. Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion. Cancer Cell. 2025;43(6):1045-60.e7. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.015.","journal-title":"Cancer Cell"},{"issue":"11","key":"1453_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","volume":"18","author":"RA Casero Jr.","year":"2018","unstructured":"Casero RA Jr., Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer. 2018;18(11):681\u201395. https:\/\/doi.org\/10.1038\/s41568-018-0050-3.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1453_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41568-022-00473-2","volume":"22","author":"CE Holbert","year":"2022","unstructured":"Holbert CE, Cullen MT, Casero RA Jr., Stewart TM. Polyamines in cancer: integrating organismal metabolism and antitumour immunity. Nat Rev Cancer. 2022;22(8):467\u201380. https:\/\/doi.org\/10.1038\/s41568-022-00473-2.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1453_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/cco.0000000000001134","volume":"37","author":"LA Sena","year":"2025","unstructured":"Sena LA. Polyamine metabolism in prostate cancer. Curr Opin Oncol. 2025;37(3):223\u201332. https:\/\/doi.org\/10.1097\/cco.0000000000001134.","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"1453_CR10","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1158\/0008-5472.Can-25-1532","volume":"86","author":"R Kumar","year":"2026","unstructured":"Kumar R, Jonnatan S, Sanin DE, et al. Androgen receptor drives polyamine synthesis, creating a vulnerability for prostate cancer. Cancer Res. 2026;86(5):1148\u201365. https:\/\/doi.org\/10.1158\/0008-5472.Can-25-1532.","journal-title":"Cancer Res"},{"key":"1453_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094382","author":"Q Peng","year":"2021","unstructured":"Peng Q, Wong CY, Cheuk IW, Teoh JY, Chiu PK, Ng CF. The emerging clinical role of spermine in prostate cancer. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094382.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1453_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-021-00242-z","volume":"9","author":"MK Andersen","year":"2021","unstructured":"Andersen MK, H\u00f8iem TS, Claes BSR, et al. Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI. Cancer Metab. 2021;9(1):9. https:\/\/doi.org\/10.1186\/s40170-021-00242-z.","journal-title":"Cancer Metab"},{"issue":"3","key":"1453_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.prnil.2023.07.003","volume":"11","author":"S Isotani","year":"2023","unstructured":"Isotani S, Ka-Fung Chiu P, Ashizawa T, et al. Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men. Prostate Int. 2023;11(3):180\u20135. https:\/\/doi.org\/10.1016\/j.prnil.2023.07.003.","journal-title":"Prostate Int"},{"issue":"1","key":"1453_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01087-9","volume":"11","author":"B Ranxhi","year":"2025","unstructured":"Ranxhi B, Bangash ZR, Chbihi ZM, et al. Regulation of polyamine interconversion enzymes affects \u03b1-Synuclein levels and toxicity in a Drosophila model of Parkinson\u2019s disease. NPJ Park Dis. 2025;11(1):231. https:\/\/doi.org\/10.1038\/s41531-025-01087-9.","journal-title":"NPJ Park Dis"},{"issue":"1","key":"1453_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07589-7","volume":"24","author":"C Chen","year":"2025","unstructured":"Chen C, Zhang Y, Wang G, et al. ZDHHC9 and spermine metabolism: a palmitoylation-driven pathway to prostate carcinogenesis. J Transl Med. 2025;24(1):103. https:\/\/doi.org\/10.1186\/s12967-025-07589-7.","journal-title":"J Transl Med"},{"issue":"1","key":"1453_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00678-2","volume":"11","author":"X Dong","year":"2021","unstructured":"Dong X, Chen C, Deng X, et al. A novel mechanism for C1GALT1 in the regulation of gastric cancer progression. Cell Biosci. 2021;11(1):166. https:\/\/doi.org\/10.1186\/s13578-021-00678-2.","journal-title":"Cell Biosci"},{"issue":"1","key":"1453_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1535-7163.Mct-21-0581","volume":"21","author":"E Farah","year":"2022","unstructured":"Farah E, Zhang Z, Utturkar SM, Liu J, Ratliff TL, Liu X. Targeting DNMTs to overcome enzalutamide resistance in prostate cancer. Mol Cancer Ther. 2022;21(1):193\u2013205. https:\/\/doi.org\/10.1158\/1535-7163.Mct-21-0581.","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"1453_CR18","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1074\/jbc.RA118.006983","volume":"294","author":"E Farah","year":"2019","unstructured":"Farah E, Li C, Cheng L, et al. NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. J Biol Chem. 2019;294(21):8543\u201354. https:\/\/doi.org\/10.1074\/jbc.RA118.006983.","journal-title":"J Biol Chem"},{"issue":"1","key":"1453_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00448-9","volume":"19","author":"T Tian","year":"2024","unstructured":"Tian T, Leng Y, Tang B, et al. The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer. Biol Direct. 2024;19(1):1. https:\/\/doi.org\/10.1186\/s13062-023-00448-9.","journal-title":"Biol Direct"},{"issue":"13","key":"1453_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319429121","volume":"121","author":"X Han","year":"2024","unstructured":"Han X, Wang D, Yang L, et al. Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer. Proc Natl Acad Sci U S A. 2024;121(13):e2319429121. https:\/\/doi.org\/10.1073\/pnas.2319429121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1453_CR21","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.immuni.2024.05.025","volume":"57","author":"H Xu","year":"2024","unstructured":"Xu H, Zhang X, Wang X, et al. Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity. Immunity. 2024;57(8):1796-811.e8. https:\/\/doi.org\/10.1016\/j.immuni.2024.05.025.","journal-title":"Immunity"},{"issue":"1","key":"1453_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41467-019-13950-4","volume":"11","author":"HC Affronti","year":"2020","unstructured":"Affronti HC, Rowsam AM, Pellerite AJ, et al. Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy. Nat Commun. 2020;11(1):52. https:\/\/doi.org\/10.1038\/s41467-019-13950-4.","journal-title":"Nat Commun"},{"issue":"5","key":"1453_CR23","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1158\/0008-5472.Can-25-4807","volume":"86","author":"M Alizadeh-Ghodsi","year":"2026","unstructured":"Alizadeh-Ghodsi M, Goldstein AS. Polyamine metabolism as a metabolic vulnerability in prostate cancer treated with supraphysiological androgens. Can Res. 2026;86(5):1095\u20137. https:\/\/doi.org\/10.1158\/0008-5472.Can-25-4807.","journal-title":"Can Res"},{"issue":"1","key":"1453_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12885-022-09313-w","volume":"22","author":"Y Mou","year":"2022","unstructured":"Mou Y, Zhang L, Liu Z, Song X. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma. BMC Cancer. 2022;22(1):215. https:\/\/doi.org\/10.1186\/s12885-022-09313-w.","journal-title":"BMC Cancer"},{"issue":"1","key":"1453_CR25","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1038\/s41467-025-58525-8","volume":"16","author":"C Zheng","year":"2025","unstructured":"Zheng C, Niu G, Tan H, et al. A noncanonical role of SAT1 enables anchorage independence and peritoneal metastasis in ovarian cancer. Nat Commun. 2025;16(1):3174. https:\/\/doi.org\/10.1038\/s41467-025-58525-8.","journal-title":"Nat Commun"},{"issue":"36","key":"1453_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309903","volume":"11","author":"W Tian","year":"2024","unstructured":"Tian W, Zhu L, Luo Y, et al. Autophagy deficiency induced by SAT1 potentiates tumor progression in triple-negative breast cancer. Adv Sci. 2024;11(36):e2309903. https:\/\/doi.org\/10.1002\/advs.202309903.","journal-title":"Adv Sci"},{"issue":"11","key":"1453_CR27","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/pros.22996","volume":"75","author":"W Huang","year":"2015","unstructured":"Huang W, Eickhoff JC, Mehraein-Ghomi F, Church DR, Wilding G, Basu HS. Expression of spermidine\/spermine N(1) -acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis. Prostate. 2015;75(11):1150\u20139. https:\/\/doi.org\/10.1002\/pros.22996.","journal-title":"Prostate"},{"key":"1453_CR28","doi-asserted-by":"publisher","unstructured":"Zhang Y, Song XW, Zhang N et al. Ezetimibe engineered L14\u20138 suppresses advanced prostate cancer by activating PLK1\/TP53-SAT1-induced ferroptosis. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2025;12(29):e04192. https:\/\/doi.org\/10.1002\/advs.202504192.","DOI":"10.1002\/advs.202504192"},{"key":"1453_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101177","author":"Y Dang","year":"2022","unstructured":"Dang Y, He Q, Yang S, et al. FTH1- and SAT1-induced astrocytic ferroptosis is involved in Azheimer\u2019s disease: evidence from single-cell transcriptomic analysis. Pharmaceuticals (Basel, Switzerland). 2022. https:\/\/doi.org\/10.3390\/ph15101177.","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"10","key":"1453_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0332761","volume":"20","author":"J Yang","year":"2025","unstructured":"Yang J, Jiang J, Wang J, Luo L. SAT1 promotes the progression of OA by regulating TRIM33-mediated p53 acetylation to enhance ferroptosis. PLoS ONE. 2025;20(10):e0332761. https:\/\/doi.org\/10.1371\/journal.pone.0332761.","journal-title":"PLoS ONE"},{"issue":"1","key":"1453_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y.","journal-title":"Mol Cancer"},{"issue":"1","key":"1453_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6(1):402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"1453_CR33","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","volume":"3","author":"S Deng","year":"2022","unstructured":"Deng S, Wang C, Wang Y, et al. Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nat Cancer. 2022;3(9):1071\u201387. https:\/\/doi.org\/10.1038\/s43018-022-00431-9.","journal-title":"Nat Cancer"},{"issue":"6611","key":"1453_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1126\/science.abn0478","volume":"377","author":"JM Chan","year":"2022","unstructured":"Chan JM, Zaidi S, Love JR, et al. Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science. 2022;377(6611):1180\u201391. https:\/\/doi.org\/10.1126\/science.abn0478.","journal-title":"Science"},{"key":"1453_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114168","volume":"158","author":"M Sadrkhanloo","year":"2023","unstructured":"Sadrkhanloo M, Paskeh MDA, Hashemi M, et al. STAT3 signaling in prostate cancer progression and therapy resistance: an oncogenic pathway with diverse functions. Biomed Pharmacother. 2023;158:114168. https:\/\/doi.org\/10.1016\/j.biopha.2022.114168.","journal-title":"Biomed Pharmacother"},{"issue":"50","key":"1453_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aea9074","volume":"11","author":"L Yuan","year":"2025","unstructured":"Yuan L, Yu J, Xu X, et al. HERVH-derived eRNA activates a super-enhancer-driven ALDH1A3\/SAT1 axis to promote ferroptosis escape and pancreatic cancer development. Sci Adv. 2025;11(50):eaea9074. https:\/\/doi.org\/10.1126\/sciadv.aea9074.","journal-title":"Sci Adv"},{"issue":"11","key":"1453_CR37","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/pin.13158","volume":"71","author":"X Sui","year":"2021","unstructured":"Sui X, Hu N, Zhang Z, Wang Y, Wang P, Xiu G. ASMTL-AS1 impedes the malignant progression of lung adenocarcinoma by regulating SAT1 to promote ferroptosis. Pathol Int. 2021;71(11):741\u201351. https:\/\/doi.org\/10.1111\/pin.13158.","journal-title":"Pathol Int"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01453-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01453-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01453-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:02:43Z","timestamp":1789534963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01453-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1453"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01453-6","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanghai Outdo Biotech Company (No. CP-1907012). All tissue donors provided written informed consent. The Animal Ethics Committee of the Hubei University of Medicine approved the animal experiments (No. 2025\u2013115).","order":2,"name":"Ethics","label":"Ethics approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"140"}}